Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSP90AB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GTF2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PITHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTNL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHX9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on